80 related articles for article (PubMed ID: 3137644)
41. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.
Sastry J; Kellie SJ
Pediatr Hematol Oncol; 2005; 22(5):441-5. PubMed ID: 16020136
[TBL] [Abstract][Full Text] [Related]
42. Hypertonic saline in neurocritical care: Is continuous infusion appropriate?
Muizelaar JP; Shahlaie K
Crit Care Med; 2009 Apr; 37(4):1521-3. PubMed ID: 19318850
[No Abstract] [Full Text] [Related]
43. Cisplatin: a review of toxicities and therapeutic applications.
Barabas K; Milner R; Lurie D; Adin C
Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
[TBL] [Abstract][Full Text] [Related]
44. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
45. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
Hayek M; Srinivasan A
Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
[No Abstract] [Full Text] [Related]
46. Bibliography. Current world literature. Intravenous fluids.
Curr Opin Crit Care; 2010 Aug; 16(4):393-5. PubMed ID: 20631532
[No Abstract] [Full Text] [Related]
47. Prevention of capillary leak in altered permeability states.
Roffey P; Thangathurai D; Shoemaker W
Resuscitation; 2009 Dec; 80(12):1444. PubMed ID: 19818548
[No Abstract] [Full Text] [Related]
48. Cisplatin update.
Muggia FM
Semin Oncol; 1991 Feb; 18(1 Suppl 3):1-4. PubMed ID: 2003223
[No Abstract] [Full Text] [Related]
49. Ejaculate in differential diagnosis.
Rott HD
Dtsch Arztebl Int; 2012 Apr; 109(17):315; author reply 315. PubMed ID: 22611451
[No Abstract] [Full Text] [Related]
50. Cisplatin: outpatient and office hydration regimen.
Goodman M
Semin Oncol Nurs; 1987 Feb; 3(1 Suppl):36-45. PubMed ID: 3645704
[No Abstract] [Full Text] [Related]
51. [Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol].
Saint-Lorant G; Madelaine J; Galais MP; Thierry L; Chédru-Legros V
Therapie; 2005; 60(5):499-505. PubMed ID: 16433016
[TBL] [Abstract][Full Text] [Related]
52. Cisplatin.
Lancet; 1982 Feb; 1(8268):374-5. PubMed ID: 6120354
[No Abstract] [Full Text] [Related]
53. Cisplatin: contemporary treatment approaches.
Semin Oncol; 1989 Aug; 16(4 Suppl 6):1-128. PubMed ID: 2762826
[No Abstract] [Full Text] [Related]
54. H4H - hydration for health.
Lafontan M
Obes Facts; 2014; 7 Suppl 2(Suppl 2):1-5. PubMed ID: 24853345
[No Abstract] [Full Text] [Related]
55. [Administration of high doses of cisplatin in 20-minute infusions].
Cirera L; Gay M; Tomé T; Martí M; Huguet J; Plá R
Rev Clin Esp; 1988 Mar; 182(4):192-5. PubMed ID: 3137644
[No Abstract] [Full Text] [Related]
56. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
[TBL] [Abstract][Full Text] [Related]
57. Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
Dana R; Kachhwaha VS
Indian J Cancer; 1996 Dec; 33(4):168-70. PubMed ID: 9254992
[TBL] [Abstract][Full Text] [Related]
58. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.
Cornelison TL; Reed E
Gynecol Oncol; 1993 Aug; 50(2):147-58. PubMed ID: 8375728
[TBL] [Abstract][Full Text] [Related]
59. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
60. [Cisplatin in the treatment of malignant tumors].
Wang QL
Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):461-4. PubMed ID: 6426911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
